No profile data available.
Rani Therapeutics Holdings, Inc. (RANI) is a healthcare company in the pharmaceutical administration systems industry, based in San Jose, United States, with about 69 full-time employees.
It reported revenue of $1.63 million for fiscal year 2025, up 58.9% from fiscal year 2024, and net income of -$29.67 million. Its market capitalization was $112.28 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company, focusing on technologies to enable the administration of biologics and drugs orally for patients, physicians, and healthcare systems with a alternative to painful injections in the United States.
Rani Therapeutics reported $1.63 million in revenue for fiscal year 2025, up 58.9% from $1.03 million in fiscal year 2024.
$112.28 million as of October 9, 2026.
Listed companies of a similar size in the same industry (pharmaceutical administration systems) include Roivant Sciences Ltd. (ROIV), Lexaria Bioscience Corp. (LEXX), Xenetic Biosciences, Inc. (XBIO), Skinvisible, Inc. (SKVI).